The tragedy of Ebola, in its now catastrophic development, besides wiping out so many human lives is already producing a cascade of effects at a global level whose extension and broad reach are impossible to foresee.
Also drug safety evaluation (or, as it is always better to say, the benefit-damage ratio) is undergoing a change that we could consider historic, hence it is probably the first time that – at international level - the canonical rules are “suspended”, rules resulted from an evolution process of several decades.